StockDriftsStockDriftsKwangdong Pharmaceutical (009290) has 0 disclosed insider purchases and 1 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩352K ($245) in reported transaction value. The earliest filing StockDrifts holds for Kwangdong Pharmaceutical is dated 2020-07-23; the most recent is 2026-03-06. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +9.30%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | BUY | 기타 | 구준모 Goo Jun-mo | Managing Director | 2.6K | ₩8,820 | +0.7% | ₩23M ($16K) |
| 2026-02-27 | BUY | 주식매수선택권 | 이채주 Chaeju Lee | Managing Director | 5.9K | ₩9,540 | -6.9% | ₩56M ($39K) |
| 2026-02-27 | BUY | 주식매수선택권 | 박상영 Sangyoung Park | CEO (President) | 7.3K | ₩9,540 | -6.9% | ₩70M ($49K) |
| 2026-02-27 | BUY | 주식매수선택권 | 이강주 Kangju Lee | Managing Director | 4.7K | ₩9,540 | -6.9% | ₩45M ($31K) |
| 2026-02-27 | BUY | 주식매수선택권 | 구준모 Goo Jun-mo | Managing Director | 5.3K | ₩9,540 | -6.9% | ₩50M ($35K) |
| 2026-02-27 | BUY | 주식매수선택권 | 박원호 Wonho Park | Managing Director | 6.6K | ₩9,540 | -6.9% | ₩63M ($44K) |
| 2026-02-27 | BUY | 주식매수선택권 | 설상현 Seol Sang-hyeon | Managing Director | 5.9K | ₩9,540 | -6.9% | ₩56M ($39K) |
| 2026-02-27 | BUY | 주식매수선택권 | 배기룡 Bae Ki-ryong | Managing Director | 5.9K | ₩9,540 | -6.9% | ₩56M ($39K) |
| 2020-07-23 | SELL | Market Sell | 이강주 Kangju Lee | Managing Director | -36 | ₩9,790 | +9.3% | ₩352K ($245) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Kwangdong Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.